Pharvaris Netherlands B.v.
Clinical trials sponsored by Pharvaris Netherlands B.v., explained in plain language.
-
Daily pill could stop painful swelling attacks for HAE patients
Disease control Recruiting nowThis study tests a once-daily pill called deucrictibant to prevent sudden, painful swelling attacks in people aged 12 and older with hereditary angioedema (HAE). The goal is to see if the drug is safe and effective over the long term. About 170 participants will take the pill dai…
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated May 17, 2026 11:02 UTC
-
New pill could stop rare swelling attacks in their tracks
Disease control Recruiting nowThis study tests an oral medication called deucrictibant for adults with acquired angioedema, a rare condition causing sudden, painful swelling. The drug comes in two forms: a long-acting tablet to prevent attacks and a fast-acting capsule to stop attacks once they start. About 3…
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated May 17, 2026 10:50 UTC